Pfizer Inc
NYSE: PFE
$26.72
Closing Price on November 8, 2024
PFE Articles
Investors with big gains on aggressive technology stocks may want to move some capital to the six highest-paying blue chip dividend stocks to buy in July.
Published:
Nothing Even Comes Close Lee and I have a list of stocks we love to hate, and one of Lee’s picks is Pfizer (NYSE: PFE). Despite the success of their COVID-19 vaccine, Pfizer has struggled with...
Published:
24/7 Insights Dividend stocks for many reasons often end up as value stocks and that spells opportunity. High-yield dividend stocks offer incredible passive income streams. Check out this hot offer:...
Published:
24/7 Insights Wounded blue chip stocks can offer huge total return potential. Stocks that pay big dividends can help provide long-term passive income streams. Access two legendary, high-yield...
Published:
Wall Street expectations for where Eli Lilly stock is headed this year vary considerably, but some analysts still have faith.
Published:
24/7 Insights Passive income is one of the best ways to supplement Social Security or pension income. By this time next year, interest rates should start to come down. Access 2 legendary, high-yield...
Published:
24/7 Insights Dividend stocks can supply investors with a steady stream of passive income. Value stocks are typically companies with prices lower than what their fundamentals suggest they should be....
Published:
If investors expect interest rates to hold until next year, they should consider dividend-yielding stocks like Altria (NYSE: MO), Bristol Myers, and Pfizer (NYSE: PFE), which offer reasonable values...
Published:
SCHD and VOO are two very popular ETFs for investors looking to diversify quickly. Like all ETFs, these two investment vehicles hold a “bucket” of stocks. However, the stocks they hold are very...
Published:
24/7 Insights Dividend stocks are one of the best ideas to generate passive income. Wells Fargo is very positive on High Yield Equity Income ideas. Access 2 legendary, high-yield dividend stocks Wall...
Published:
24/7 Wall Street Insights Unlike the declining stocks of some of its pharmaceutical rivals, Eli Lilly has continually beat analysts’ forecasts and prospered accordingly. In 5 Years, Eli Lilly has...
Published:
24/7 Insights Sell in May and go away? Maybe not this year, but be careful. Altria Group Inc. (NYSE MO) still owns 8% of Anheuser-Busch InBev S.A. (NYSE: BUD) after selling millions of shares. In...
Published:
Investors love dividend stocks because they provide dependable income and give investors a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and...
Published:
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital...
Published:
Private healthcare sure does seem to be working well in America, doesn’t it? With skyrocketing healthcare costs with diminishing returns, a lower life expectancy, unofficial waitlists, and absurdly...
Published: